Hura Imaging is a medical imaging software company that specializes in AI innovations for imaging-guided treatment. Their mission is to enhance the safety, efficiency, and quality of the medical imaging process, with a particular focus on imaging-guided treatment. The company offers a range of cutting-edge technologies that have received FDA clearance, including HuraCTP®, the first and only denoising software dedicated to CT perfusion.

This physics-based AI algorithm significantly improves image quality, benefiting all CT models and validated by extensive multi-center studies. Hura Imaging also provides HuraASL® (CereFlow), the first comprehensive commercial software for arterial spin labeling perfusion MRI. Supported by multiple studies and publications, it delivers multiparametric perfusion maps and auto-processing of multi-delay pCASL data.

Their HuraRT® (DV. Target) technology, an FDA-approved deep learning product, achieves superior results in time-saving and contouring for treatment planning. Hura's technologies bring numerous benefits, including improving diagnostic accuracy and efficiency for clinicians, reducing radiation and contrast agent use for patient safety, and enhancing healthcare service provision for payers.

They have also received funding and recognition from prestigious organizations like the NIH. Hura Imaging is backed by a team of renowned experts in the field, and their headquarters are located at 1100 Glendon Ave, Suite 1730, Los Angeles, CA 90024. For more information about their innovative solutions, you can visit their website at www.

huraimaging. com or contact them directly at bd@huraimaging. com